Pharmacokinetics and pharmacodynamics of infliximab, an anti-tumor necrosis factor-alpha monoclonal antibody, following single subcutaneous administrations in rheumatoid arthritis patients

Tumor Necrosis ◽

Pharmacokinetics And Pharmacodynamics ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80164-9 ◽

2003 ◽

Vol 25 (6) ◽

pp. 1700-1721 ◽

Cited By ~ 203

Author(s):

Michael H. Weisman ◽

Larry W. Moreland ◽

Daniel E. Furst ◽

Michael E. Weinblatt ◽

Edward C. Keystone ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Pilot Study ◽

Tumor Necrosis Factor ◽

Safety Assessment ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Faculty Opinions recommendation of Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166921.629011 ◽

2009 ◽

Author(s):

Will Dixon

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Cancer Risk ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Faculty Opinions recommendation of Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718203203.793488248 ◽

2013 ◽

Author(s):

Ali Mobasheri

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Synovial Fluid ◽

Tumor Necrosis ◽

Rheumatoid Arthritis Synovial Fluid ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis

Modern Rheumatology ◽

10.3109/s10165-011-0475-y ◽

2012 ◽

Vol 22 (1) ◽

pp. 128-136 ◽

Cited By ~ 18

Author(s):

Yoko Tanaka ◽

Isao Matsumoto ◽

Keiichi Iwanami ◽

Asuka Inoue ◽

Reiko Minami ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cell Proliferation ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Engineered Human Anti-Tumor Necrosis Factor-Alpha (TNFα) Antibody, CDP571, in Rheumatoid Arthritis

Novel Therapeutic Agents for the Treatment of Autoimmune Diseases ◽

10.1201/9781482273533-21 ◽

1996 ◽

pp. 143-152

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Relation Between Disease Activation, and Serum Erythrocyte Sediment Level and C-reactive Protein Levels in Rheumatoid Arthritis Patients Receiving Anti Tumor Necrosis Factor Alpha Treatment

Eurasian Journal of Medicine and Oncology ◽

10.14744/ejmo.2017.47955 ◽

2017 ◽

Author(s):

Gülçin Güngör Olçum

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

C Reactive Protein ◽

Necrosis Factor Alpha ◽

Protein Levels ◽

Reactive Protein ◽

Factor Alpha ◽

Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30082-6 ◽

2016 ◽

Vol 36 (5) ◽

pp. 625-633 ◽

Cited By ~ 2

Author(s):

Liu Defang ◽

Yan Jiao ◽

Yun Mingdong ◽

Yang Ming ◽

Luo Yong ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Synovial Fluid ◽

Interferon Gamma ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Symptom Pattern ◽

Factor Alpha ◽

Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors

Pharmacogenetics and Genomics ◽

10.1097/fpc.0000000000000446 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Woorim Kim ◽

Hyun Jeong Kim ◽

Nga Thi Trinh ◽

Ha Rim Yeon ◽

Joo Hee Kim ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

T Cells ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Nuclear Factor ◽

Activated T Cells ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Private Market in Mexico

Value in Health ◽

10.1016/j.jval.2015.09.387 ◽

2015 ◽

Vol 18 (7) ◽

pp. A843

Author(s):

CA Pichardo-Piña ◽

JL Sánchez-Casillas ◽

JC Pozos-Espíndola

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Cost Minimization ◽

Necrosis Factor Alpha ◽

Private Market ◽

Factor Alpha ◽

Immunosuppressive Cytokines ◽

Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients

Clinical Rheumatology ◽

10.1007/s10067-008-0893-1 ◽

2008 ◽

Vol 27 (10) ◽

pp. 1243-1248 ◽

Cited By ~ 25

Author(s):

Omer Ates ◽

Gulen Hatemi ◽

Vedat Hamuryudan ◽

Aysegul Topal-Sarikaya

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Gene Promoter ◽

Interleukin 10 ◽

Promoter Polymorphisms ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽